DUBLIN, Ohio, Feb. 3 /PRNewswire-FirstCall/ -- Cardinal Health CFO J. Michael Losh will address investors at the Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference on Wednesday, Feb. 9 at 2 p.m. eastern standard time, the company said today.
Mr. Losh will discuss Cardinal Health's diverse products and services, company performance and strategies for continued growth. His remarks will be webcast live at http://www.wsw.com/webcast/ml32/cah/ .
About Cardinal Health
Cardinal Health, Inc. ( http://www.cardinalhealth.com/ ) is the leading provider of products and services supporting the health care industry. Cardinal Health develops, manufactures, packages and markets products for patient care; develops drug-delivery technologies; distributes pharmaceuticals and medical, surgical and laboratory supplies; and offers consulting and other services that improve quality and efficiency in health care. Headquartered in Dublin, Ohio, Cardinal Health employs more than 55,000 people on six continents and produces annual revenues of more than $65 billion.
Cardinal Health, Inc.CONTACT: Media, Jim Mazzola, +1-614-757-3690, orjim.mazzola@cardinal.com , or Investors, Jim Hinrichs, +1-614-757-7828, orjim.hinrichs@cardinal.com , both of Cardinal Health, Inc.
